CN116603040A - 一种治疗遗尿的膏方 - Google Patents
一种治疗遗尿的膏方 Download PDFInfo
- Publication number
- CN116603040A CN116603040A CN202310729567.1A CN202310729567A CN116603040A CN 116603040 A CN116603040 A CN 116603040A CN 202310729567 A CN202310729567 A CN 202310729567A CN 116603040 A CN116603040 A CN 116603040A
- Authority
- CN
- China
- Prior art keywords
- fruit
- enuresis
- treating
- honey
- ointment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000008967 Enuresis Diseases 0.000 title claims abstract description 27
- 239000002674 ointment Substances 0.000 title claims abstract description 18
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 28
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 12
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 12
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 12
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 12
- 241001278833 Rosa laevigata Species 0.000 claims abstract description 11
- 235000000661 Rosa laevigata Nutrition 0.000 claims abstract description 11
- 235000012907 honey Nutrition 0.000 claims abstract description 11
- 244000268590 Euryale ferox Species 0.000 claims abstract description 10
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 10
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 9
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 9
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 9
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 9
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 9
- 239000004863 Frankincense Substances 0.000 claims abstract description 9
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 9
- 240000007651 Rubus glaucus Species 0.000 claims abstract description 9
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 9
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 9
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 8
- 240000006766 Cornus mas Species 0.000 claims abstract 4
- 235000021028 berry Nutrition 0.000 claims description 5
- 235000008671 Calycanthus floridus Nutrition 0.000 claims description 3
- 235000008670 Calycanthus occidentalis Nutrition 0.000 claims description 3
- 244000148992 Lindera benzoin Species 0.000 claims description 3
- 235000004520 Lindera benzoin Nutrition 0.000 claims description 3
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000011505 plaster Substances 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 239000008213 purified water Substances 0.000 abstract description 3
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 description 13
- 230000027939 micturition Effects 0.000 description 13
- 238000011282 treatment Methods 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 241000209020 Cornus Species 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010059013 Nocturnal emission Diseases 0.000 description 4
- 206010041497 Spermatorrhoea Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 241000572565 Alpinia oxyphylla Species 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 208000005346 nocturnal enuresis Diseases 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 description 2
- XIQVNETUBQGFHX-UHFFFAOYSA-N Ditropan Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCC#CCN(CC)CC)C1CCCCC1 XIQVNETUBQGFHX-UHFFFAOYSA-N 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 238000013542 behavioral therapy Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 229960004281 desmopressin Drugs 0.000 description 2
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 208000026500 emaciation Diseases 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 206010029446 nocturia Diseases 0.000 description 2
- 229960005434 oxybutynin Drugs 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000546273 Lindera <angiosperm> Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000000693 Neurogenic Urinary Bladder Diseases 0.000 description 1
- 206010029279 Neurogenic bladder Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 208000024716 acute asthma Diseases 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 229960004801 imipramine Drugs 0.000 description 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药膏方技术领域,更具体的说是涉及一种治疗遗尿的膏方。一种治疗遗尿的膏方,包括以下成分:益智仁,乌药,山药,金樱子,蜂蜜,五味子,没药,山茱萸,芡实,覆盆子,乳香;对原料进行提取、混合等工艺后,加入硬脂醇、纯化水等辅料加工制成;本发明制备方法简单,见效快、治愈率高,无毒副作用,并加入蜂蜜调和,易被患者所接受。
Description
技术领域
本发明涉及中药膏方技术领域,更具体的说是涉及一种治疗遗尿的膏方。
背景技术
遗尿症俗称尿床,通常指小儿在熟睡时不自主地排尿。一般至4岁时仅20%有遗尿,10岁时5%有遗尿,有少数患者遗尿症状持续到成年期。没有明显尿路或神经系统器质性病变者称为原发性遗尿,约占70%~80%。继发于下尿路梗阻(如尿道瓣膜)、膀胱炎、神经原性膀胱(神经病变引起的排尿功能障碍)等疾患者称为继发性遗尿,患儿除夜间尿床外,日间常有尿频、尿急或排尿困难、尿流细等症状。
通常治疗手段分为1.一般治疗;2.儿童尿床的行为疗法;3.药物治疗;4.物理疗法,其中一般治疗和行为疗法为习惯养成,通过有意识的训练孩童的主动行为对其进行改正,缺点是见效慢且孩童的自我意识不够完善,常常事倍功半;物理疗法是通过针灸、按摩、电针等器械对孩童进行物理干预,其缺点是针灸、电针会对孩童心理产生影响,产生畏惧心理,并不推荐;现有的药物治疗大多使用丙咪嗪、奥昔布宁、麻黄素、去氨加压素,联合应用阿米替林、去氨加压素和奥昔布宁是目前认为治疗顽固性混合型遗尿症有效的三联药物。以个月为一疗程,优点是有效率,缺点是有不同程度的副作用并且停药后易复发。
因此,本领域技术人员亟需提供一种见效快、副作用小的遗尿配方,填补这一方面的空白。
发明内容
有鉴于此,本发明提供了一种安全、快速治疗遗尿的膏方。
为实现上述目的,本发明提供如下技术方案,一种治疗遗尿的膏方,包括以下成分:益智仁,乌药,山药,金樱子,蜂蜜,五味子,没药,山茱萸,芡实,覆盆子,乳香。
进一步的,在上述一种治疗遗尿的膏方中,以质量百分比计,包括:益智仁25-30%,乌药25-30%,山药10-20%,金樱子5-10%,蜂蜜3-8%,五味子3-5%,没药4-6%,山茱萸1-2%,芡实1-2%,覆盆子1-2%,乳香1-2%。
进一步的,在上述一种治疗遗尿的膏方中,以质量百分比计,包括:益智仁25%,乌药25%,山药15%,金樱子10%,蜂蜜8%,五味子5%,没药4%,山茱萸2%,芡实2%,覆盆子2%,乳香2%。
经由上述的技术方案可知,与现有技术相比,本发明公开提供了一种治疗遗尿的膏方,对原料进行提取、混合等工艺后,加入硬脂醇、纯化水等辅料加工制成;本发明制备方法简单,见效快、治愈率高,无毒副作用,并加入蜂蜜调和,易被患者所接受。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
其中,部分原料的功效及作用如下:
益智仁:温脾止泻摄唾,暖肾固精缩尿。用于脾寒泄泻,腹中冷痛,口多唾涎,肾虚遗尿,小便频数,遗精白浊。
古籍记载:治梦泄:益智仁二两(用盐二两炒,去盐),乌药二两,上为末,用山药一两为糊,和丸如梧桐子大,每服五十丸,空心临卧盐汤下,以朱砂为衣。(《世医得效方》三仙丸);
治小儿遗尿,亦治白浊:益智仁、白茯苓各等分,上为末。每服一钱,空心米汤调下。(《补要袖珍小儿方论》益智仁散);
治小便赤浊:益智仁、茯神各二两,远志、甘草(水煮)各半斤。为末,酒糊丸,梧子大。空心姜汤下五十丸。(《纲目》)。
乌药:用于寒凝气滞,胸腹胀痛,气逆喘急,膀胱虚冷,遗尿尿频,疝气疼痛,经寒腹痛。
古籍记载:缩泉丸:与益智仁、山药等同用,治肾阳不足、膀胱虚冷之小便频数、小儿遗尿(《校注妇人良方》)。
山药:滋补脾胃的食物首推山药,它是入肺、健脾、补肾的佳品。山药黏糊糊的汁液主要是黏蛋白,能保持血管弹性,还有润肺止咳的功能。山药可与红枣搭配熬粥,或用于煲汤,也可与各种食材清炒。
金樱子:具有固精缩尿,固崩止带,涩肠止泻之功效。常用于遗精滑精,遗尿尿频,崩漏带下,久泻久痢。
古籍记载:治梦遗,精不固:金樱子十斤,剖开去子毛,于木臼内杵碎。水二升,煎成膏子服。(《明医指掌》金樱子膏)。
五味子:敛肺,滋肾,生津,收汗,涩精。治肺虚喘咳,口干作渴,自汗,盗汗,劳伤羸瘦,梦遗滑精,久泻久痢。
古籍记载:五味子,敛气生津之药也。故《唐本草》主收敛肺虚久嗽耗散之气。凡气虚喘急,咳逆劳损,精神不足,脉势空虚,或劳伤阳气,肢体赢瘦,或虚气上乘,自汗频来,或精元耗竭,阴虚火炎,或亡阴亡阳,神散脉脱,以五味子治之,咸用其酸敛生津,保固元气而无遗泄也。然在上入肺,在下入肾,入肺有生津济源之益,入肾有固精养髓之功(《本草汇言》)。
山茱萸:为收敛性补血剂及强壮剂;可健胃、补肝肾、治贫血、腰痛、神经及心脏衰弱等症。其性味酸涩、入肝、肾经。酸涩收敛,有滋肝补肾、固肾涩精的作用,适用于肝肾不足所致的腰膝酸软、遗精滑泄、眩晕耳鸣之症。
芡实:其味酸涩,具有滋补、健胃、利尿、补肝肾,益气血等功效。主治血压高、腰膝酸痛、眩晕耳鸣、阳萎遗精、月经过多等症。
实施例1
组成成分为:益智仁25%,乌药25%,山药15%,金樱子10%,蜂蜜8%,五味子5%,没药4%,山茱萸2%,芡实2%,覆盆子2%,乳香2%。
制备步骤如下:
S1:准备原料:益智仁,乌药,山药,金樱子,蜂蜜,五味子,没药,山茱萸,芡实,覆盆子,乳香;
S2:将固体原料进行粉碎处理,筛选提取,并与蜂蜜等混合;
S3:将制备的混合药物加入硬脂醇、纯化水等辅料加工制成膏方。
实验结果:征集10岁以上患有遗尿症的患者作为志愿者,试用本申请提供的治疗遗尿症的中药膏方,患者表现有夜尿频多、尿急、睡中尿床等症状。共征集100位志愿者患者,其中男60人,女40人,年龄10-50岁。将上述志愿者患者按年龄区间分为4组,分别使用本发明提供的治疗遗尿的膏方。
使用方法:取本发明的中药膏方20g,直接贴敷于志愿者的神阙穴(肚脐)和肾俞穴(左),每两日一次,疗程为1个月。上述志愿者使用1个月后开始统计药效,并长期随访。
疗效判定标准如下:
(1)治愈:诊断标准中所称的症状完全消失,并能正常工作、生活、学习、劳动;
(2)有效:诊断标准中所称的症状有改善和明显改善,需继续治疗;
(3)无效:诊断标准中所称的症状无改善,甚有加重之趋势,需另选择其他它药物治疗。
药效统计如表1所示。
从表一可以看出,本发明提供的药剂的总有效率在80%以上,且治愈率在60%以上。
本说明书中各个实施例采用递进的方式描述,每个实施例重点说明的都是与其他实施例的不同之处,各个实施例之间相同相似部分互相参见即可。对于实施例公开的装置而言,由于其与实施例公开的方法相对应,所以描述的比较简单,相关之处参见方法部分说明即可。
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (3)
1.一种治疗遗尿的膏方,其特征在于,包括以下成分:益智仁,乌药,山药,金樱子,蜂蜜,五味子,没药,山茱萸,芡实,覆盆子,乳香。
2.根据权利要求1所述的治疗遗尿的膏方,其特征在于,以质量百分比计,包括:益智仁25-30%,乌药25-30%,山药10-20%,金樱子5-10%,蜂蜜3-8%,五味子3-5%,没药4-6%,山茱萸1-2%,芡实1-2%,覆盆子1-2%,乳香1-2%。
3.根据权利要求2所述的治疗遗尿的膏方,其特征在于,以质量百分比计,包括:益智仁25%,乌药25%,山药15%,金樱子10%,蜂蜜8%,五味子5%,没药4%,山茱萸2%,芡实2%,覆盆子2%,乳香2%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310729567.1A CN116603040A (zh) | 2023-06-20 | 2023-06-20 | 一种治疗遗尿的膏方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310729567.1A CN116603040A (zh) | 2023-06-20 | 2023-06-20 | 一种治疗遗尿的膏方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116603040A true CN116603040A (zh) | 2023-08-18 |
Family
ID=87685517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310729567.1A Pending CN116603040A (zh) | 2023-06-20 | 2023-06-20 | 一种治疗遗尿的膏方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116603040A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109939195A (zh) * | 2017-12-20 | 2019-06-28 | 袁龙 | 一种治疗遗尿的膏方及制备方法 |
-
2023
- 2023-06-20 CN CN202310729567.1A patent/CN116603040A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109939195A (zh) * | 2017-12-20 | 2019-06-28 | 袁龙 | 一种治疗遗尿的膏方及制备方法 |
Non-Patent Citations (1)
Title |
---|
周国钧: "遗尿证临床研究近况", 新中医, no. 03, pages 51 - 55 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104288651A (zh) | 一种治疗产后缺乳的药物及其制备方法 | |
CN104758854A (zh) | 一种治疗卵巢功能早衰的中药制剂及其制备方法 | |
CN104667222A (zh) | 一种养胃健脾的中药 | |
CN109966462A (zh) | 一种调理体质的膏方及其制备方法 | |
CN104623561A (zh) | 一种治疗乳腺增生的中药 | |
CN104825914A (zh) | 一种辅助治疗乳腺癌症的中药制剂 | |
CN114306563A (zh) | 一种妇科更年期经方艾灸及其制备方法 | |
CN107007724B (zh) | 一种中药保健液及其制备方法 | |
CN106110017A (zh) | 一种中药药枕 | |
CN105878574A (zh) | 一种治疗肾虚的中药组合物及其制备方法 | |
CN104721754A (zh) | 一种治疗气滞血瘀型黄褐斑的中药制剂 | |
CN104474202B (zh) | 一种治疗厌食的药物组合物 | |
CN116603040A (zh) | 一种治疗遗尿的膏方 | |
CN103495103B (zh) | 消食健脾的药物 | |
CN108261506B (zh) | 一种治疗脱发的药物 | |
CN101564527A (zh) | 一种治疗癌性腹泻的中西药结合配方及其加工方法 | |
CN111265609A (zh) | 一种辅助治疗真性近视的中药组合物及其制备方法 | |
CN105169189A (zh) | 一种治疗甲减的药物 | |
CN104274809A (zh) | 一种治疗经期头痛的中药组合物及其制备方法 | |
CN108653572A (zh) | 一种治疗便秘的中药口服剂及制备方法 | |
CN103301403A (zh) | 一种治疗癌症晚期疼痛的中药组合物 | |
CN103494991B (zh) | 一种治疗妇女崩漏的中药制剂及制备方法 | |
CN106237249A (zh) | 一种用于治疗女性更年期失眠的中药胶囊 | |
CN117281876A (zh) | 一种中药外治药包 | |
CN105169111A (zh) | 一种用于治疗慢性荨麻疹的中药组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |